Step into a model designed for adaptability, speed, and success in specialized drug development.

The pharmaceutical industry faces increasing complexity in drug development and clinical supply, particularly for small and mid-sized biotechs that struggle to find partners offering both technical expertise and personalized attention. Experic was founded to bridge this gap, providing a unique combination of GMP-compliant clinical supply services, cutting-edge manufacturing capabilities, and hands-on collaboration. With a purpose-built facility in Cranbury, New Jersey, featuring advanced encapsulation and inhalation drug expertise, Experic offers customers a seamless, transparent development experience. Its integration with Harro Höfliger’s state-of-the-art equipment and focus on flexibility allow it to compete with larger CDMOs while maintaining a customer-first approach. In this Q&A with Pharma’s Almanac Editor-in-Chief David Alvaro, Ph.D., David Wood, Experic’s Chairman and Chief Executive Officer, discusses the company’s origins, key differentiators, and vision for the future of clinical supply and inhaled drug development.